Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,050 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer

NCT00058045

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

FR901228 in Treating Patients With Hematologic Cancer

NCT00024180

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
Locations: Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia

NCT00054171

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function

NCT00275093

Conditions: Hemic and Lymphatic Diseases, Hepatic Complications, Immune System Diseases, +7 more
Locations: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma

NCT00016094

Conditions: Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +22 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder

NCT00064246

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +32 more
Locations: AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States

View Trial Details

Completed

17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

NCT00089271

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +97 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Bortezomib-Dexamethasone-Doxorubicin-Study

NCT00401804

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +20 more
Locations: Landeskrankenhaus Feldkirch Feldkirch, Austria

Klinischen Abteilung für Hämatologie, Medizinische Universitätsklinik Graz Graz, Austria

Landeskrankenhaus Leoben Leoben, Austria

Dep. of Internal Medicine I, Oncology, SALK - Gemeinnützige Salzburger Landeskliniken Salzburg, Austria

View Trial Details

Completed

MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas

NCT00098891

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +92 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma

NCT00003970

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +99 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions